转移相关基因家族与宫颈癌关系的研究进展

吕佳玟, 卢丹

吕佳玟, 卢丹. 转移相关基因家族与宫颈癌关系的研究进展[J]. 实用临床医药杂志, 2025, 29(4): 129-133. DOI: 10.7619/jcmp.20242655
引用本文: 吕佳玟, 卢丹. 转移相关基因家族与宫颈癌关系的研究进展[J]. 实用临床医药杂志, 2025, 29(4): 129-133. DOI: 10.7619/jcmp.20242655
LYU Jiawen, LU Dan. Research progress in relationship between metastasis-associated gene family and cervical cancer[J]. Journal of Clinical Medicine in Practice, 2025, 29(4): 129-133. DOI: 10.7619/jcmp.20242655
Citation: LYU Jiawen, LU Dan. Research progress in relationship between metastasis-associated gene family and cervical cancer[J]. Journal of Clinical Medicine in Practice, 2025, 29(4): 129-133. DOI: 10.7619/jcmp.20242655

转移相关基因家族与宫颈癌关系的研究进展

基金项目: 

国家自然科学基金项目 82072088

详细信息
    通讯作者:

    卢丹

  • 中图分类号: R711.74;R329.2;R271.9

Research progress in relationship between metastasis-associated gene family and cervical cancer

  • 摘要:

    宫颈癌是原发于子宫颈部位的恶性肿瘤, 其是女性生殖道最常见的恶性肿瘤。近年来,随着对肿瘤机制的深入研究,肿瘤形成和转移信号通路中的关键调控因子一一被发现,其中转移相关基因(MTA)是一类新发现的肿瘤进展相关基因家族。研究证明, MTA家族与妇科恶性肿瘤的发生密切相关,但针对宫颈癌的相关性研究尚少。本文对MTA家族与宫颈癌之间的关系进行阐述,以明确其在宫颈癌发生与发展中的作用,从而为宫颈癌的预防、诊断、预后评估和治疗提供新的视角。

    Abstract:

    Cervical cancer is a malignant tumor that originates in the cervix of the uterus, which is the most common malignant tumor in the female reproductive tract. In recent years, with the deepening understanding of tumor mechanisms, key regulatory factors in tumor formation and metastasis signaling pathways have been identified. Among these, the metastasis-associated gene (MTA) family represents a newly discovered group of genes associated with tumor progression. Studies have demonstrated that the MTA family is closely related to the development of gynecological malignancies; however, research specifically addressing its association with cervical cancer remains limited. This review aimed to elucidate the relationship between the MTA family and cervical cancer, to clarify their roles in the initiation and progression of the disease, thereby providing new roles for the prevention, diagnosis, prognosis, and treatment of cervical cancer.

  • 图  1   MTA家族在宫颈癌发生和进展中的作用机制

  • [1]

    SMALL W, BACON M A, BAJAJ A, et al. Cervical cancer: a global health crisis[J]. Cancer, 2017, 123(13): 2404-2412. doi: 10.1002/cncr.30667

    [2]

    KUNNUMMAL M, ANGELIN M, DAS A V. PIWI proteins and piRNAs in cervical cancer: a propitious dart in cancer stem cell-targeted therapy[J]. Hum Cell, 2021, 34(6): 1629-1641. doi: 10.1007/s13577-021-00590-4

    [3]

    TOH Y, NICOLSON G L. The role of the MTA family and their encoded proteins in human cancers: molecular functions and clinical implications[J]. Clin Exp Metastasis, 2009, 26(3): 215-227. doi: 10.1007/s10585-008-9233-8

    [4]

    BRVNING A, BLANKENSTEIN T, JVCKSTOCK J, et al. Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system[J]. Cancer Metastasis Rev, 2014, 33(4): 943-951. doi: 10.1007/s10555-014-9520-6

    [5]

    MANAVATHI B, SINGH K, KUMAR R. MTA family of coregulators in nuclear receptor biology and pathology[J]. Nucl Recept Signal, 2007, 5: e010.

    [6]

    YAO Y L, YANG W M. The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity[J]. J Biol Chem, 2003, 278(43): 42560-42568. doi: 10.1074/jbc.M302955200

    [7]

    SIMPSON A, UITTO J, RODECK U, et al. Differential expression and subcellular distribution of the mouse metastasis-associated proteins Mta1 and Mta3[J]. Gene, 2001, 273(1): 29-39. doi: 10.1016/S0378-1119(01)00563-7

    [8]

    MARTIN M D, FISCHBACH K, OSBORNE C K, et al. Loss of heterozygosity events impeding breast cancer metastasis contain the MTA1 gene[J]. Cancer Res, 2001, 61(9): 3578-3580.

    [9]

    YANG N, XU R M. Structure and function of the BAH domain in chromatin biology[J]. Crit Rev Biochem Mol Biol, 2013, 48(3): 211-221. doi: 10.3109/10409238.2012.742035

    [10]

    DING Z H, GILLESPIE L L, PATERNO G D. Human MI-ER1 alpha and beta function as transcriptional repressors by recruitment of histone deacetylase 1 to their conserved ELM2 domain[J]. Mol Cell Biol, 2003, 23(1): 250-258. doi: 10.1128/MCB.23.1.250-258.2003

    [11]

    WANG L, CHARROUX B, KERRIDGE S, et al. Atrophin recruits HDAC1/2 and G9a to modify histone H3K9 and to determine cell fates[J]. EMBO Rep, 2008, 9(6): 555-562. doi: 10.1038/embor.2008.67

    [12]

    SINGH R R, KUMAR R. MTA family of transcriptional metaregulators in mammary gland morphogenesis and breast cancer[J]. J Mammary Gland Biol Neoplasia, 2007, 12(2/3): 115-125.

    [13]

    LIU J, WANG H J, MA F, et al. MTA1 regulates higher-order chromatin structure and histone H1-chromatin interaction in-vivo[J]. Mol Oncol, 2015, 9(1): 218-235. doi: 10.1016/j.molonc.2014.08.007

    [14]

    LIU J, WANG H J, HUANG C Z, et al. Subcellular localization of MTA proteins in normal and cancer cells[J]. Cancer Metastasis Rev, 2014, 33(4): 843-856. doi: 10.1007/s10555-014-9511-7

    [15]

    KUMAR R, WANG R A, MAZUMDAR A, et al. A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm[J]. Nature, 2002, 418(6898): 654-657. doi: 10.1038/nature00889

    [16]

    KUMAR R, WANG R A. Structure, expression and functions of MTA genes[J]. Gene, 2016, 582(2): 112-121. doi: 10.1016/j.gene.2016.02.012

    [17]

    COVINGTON K R, FUQUA S A W. Role of MTA2 in human cancer[J]. Cancer Metastasis Rev, 2014, 33(4): 921-928. doi: 10.1007/s10555-014-9518-0

    [18]

    NING Z F, GAN J F, CHEN C Y, et al. Molecular functions and significance of the MTA family in hormone-independent cancer[J]. Cancer Metastasis Rev, 2014, 33(4): 901-919. doi: 10.1007/s10555-014-9517-1

    [19]

    LIU Y Q, PAN B, QU W K, et al. Systematic analysis of the expression and prognosis relevance of FBXO family reveals the significance of FBXO1 in human breast cancer[J]. Cancer Cell Int, 2021, 21(1): 130. doi: 10.1186/s12935-021-01833-y

    [20]

    FUJITA N, JAYE D L, KAJITA M, et al. MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer[J]. Cell, 2003, 113(2): 207-219. doi: 10.1016/S0092-8674(03)00234-4

    [21]

    LI E. Chromatin modification and epigenetic reprogramming in mammalian development[J]. Nat Rev Genet, 2002, 3(9): 662-673. doi: 10.1038/nrg887

    [22]

    DONG H M, GUO H, XIE L X, et al. The metastasis-associated gene MTA3, a component of the Mi-2/NuRD transcriptional repression complex, predicts prognosis of gastroesophageal junction adenocarcinoma[J]. PLoS One, 2013, 8(5): e62986. doi: 10.1371/journal.pone.0062986

    [23]

    FUJITA N, JAYE D L, GEIGERMAN C, et al. MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation[J]. Cell, 2004, 119(1): 75-86. doi: 10.1016/j.cell.2004.09.014

    [24]

    WANG Y, ZHANG H, CHEN Y P, et al. LSD1 is a subunit of the NuRD complex and targets the metastasis programs in breast cancer[J]. Cell, 2009, 138(4): 660-672. doi: 10.1016/j.cell.2009.05.050

    [25]

    JEMAL A, BRAY F, CENTER M M, et al. Global cancer statistics[J]. CA: a Cancer Journal for Clinicians, 2011, 61(2): 69-90. doi: 10.3322/caac.20107

    [26]

    CAIN J M, HOWETT M K. Preventing cervical cancer[J]. Science, 2000, 288(5472): 1753-1755. doi: 10.1126/science.288.5472.1753

    [27] 李瑞. MTA2和ERK信号通路与子宫内膜样癌发病机制的相关性研究[D]. 呼和浩特: 内蒙古医科大学, 2023.
    [28]

    TOH Y, PENCIL S D, NICOLSON G L. A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses[J]. J Biol Chem, 1994, 269(37): 22958-22963. doi: 10.1016/S0021-9258(17)31603-4

    [29] 林丽慧, 闫志强, 任青, 等. CIN病变程度及HPV感染与宫颈组织MTA1、Bcl-2表达的相关性[J]. 中华医院感染学杂志, 2023, 33(10): 1559-1563.
    [30] 陈文芬, 李屹. 肿瘤转移相关基因-1蛋白在宫颈良恶性病变组织中的表达差异及意义[J]. 中国临床药理学杂志, 2020, 36(22): 3621-3623.
    [31]

    LIU T B, YANG M, YANG S S, et al. Metastasis-associated protein 1 is a novel marker predicting survival and lymph nodes metastasis in cervical cancer[J]. Hum Pathol, 2013, 44(10): 2275-2281. doi: 10.1016/j.humpath.2013.05.009

    [32]

    MATSUSUE K, TAKIGUCHI S, TOH Y, et al. Characterization of mouse metastasis-associated gene 2: genomic structure, nuclear localization signal, and alternative potentials as transcriptional activator and repressor[J]. DNA Cell Biol, 2001, 20(10): 603-611. doi: 10.1089/104454901753340596

    [33]

    COVINGTON K, TSIMELZON A, FUQUA S. MTA2 enhances breast cancer metastasis by regulating the rho signaling pathway[J]. Cancer Res, 2009, 69(24_Supplement): 6143. doi: 10.1158/0008-5472.SABCS-09-6143

    [34]

    ZHANG B, TAO F, ZHANG H. Metastasis-associated protein 2 promotes the metastasis of non-small cell lung carcinoma by regulating the ERK/AKT and VEGF signaling pathways[J]. Mol Med Rep, 2018, 17(4): 4899-4908.

    [35] 肖浪潮, 黄守国, 程虹, 等. 子宫颈鳞癌中转移相关基因2的表达及其与预后的关系[J]. 中南大学学报: 医学版, 2016, 41(10): 1031-1038. doi: 10.11817/j.issn.1672-7347.2016.10.004
    [36]

    LIN C L, YING T H, YANG S F, et al. Transcriptional suppression of miR-7 by MTA2 induces Sp1-mediated KLK10 expression and metastasis of cervical cancer[J]. Mol Ther Nucleic Acids, 2020, 20: 699-710. doi: 10.1016/j.omtn.2020.04.009

    [37]

    LIN C L, YING T H, YANG S F, et al. MTA2 silencing attenuates the metastatic potential of cervical cancer cells by inhibiting AP1-mediated MMP12 expression via the ASK1/MEK3/p38/YB1 axis[J]. Cell Death Dis, 2021, 12(5): 451. doi: 10.1038/s41419-021-03729-1

    [38]

    DANNENMANN C, SHABANI N, FRIESE K, et al. The metastasis-associated gene MTA1 is upregulated in advanced ovarian cancer, represses ERbeta, and enhances expression of oncogenic cytokine GRO[J]. Cancer Biol Ther, 2008, 7(9): 1460-1467. doi: 10.4161/cbt.7.9.6427

    [39]

    ALAWADHI M M, SHAMMARI F A, ALI F M, et al. The effect of progesterone administration on the expression of metastasis tumor antigens (MTA1 and MTA3) in placentas of normal and dexamethasone-treated rats[J]. Mol Biol Rep, 2022, 49(3): 1935-1943. doi: 10.1007/s11033-021-07005-5

    [40] 刘伟, 黄海花, 李丹妍, 等. 转移相关因子-3在宫颈癌浸润转移中的相关性研究[J]. 中国妇幼保健, 2015, 30(27): 4704-4706.
    [41] 黄海花, 吴秀浅, 李振华, 等. MTA3和E-cadherin在宫颈癌转移中的作用研究[J]. 中国医学创新, 2016, 13(28): 14-18.
图(1)
计量
  • 文章访问数:  0
  • HTML全文浏览量:  0
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2024-06-20
  • 修回日期:  2024-09-04
  • 刊出日期:  2025-02-27

目录

    /

    返回文章
    返回
    x 关闭 永久关闭